Embargoed until 7 a.m. CT / 8 a.m. ET Wednesday, Nov. 3, 2021
DALLAS, Nov. 3, 2021 The American Heart Association (AHA), a global force for longer, healthier lives, will present its 2021 Joseph A. Vita Award to Kiran Musunuru, M.D., Ph.D., M.P.H., M.L., FAHA, and Katey Rayner, Ph.D. They will receive their awards during the Presidential Session on Sunday, Nov. 14 at the AssociationsScientific Sessions 2021. The meeting will be fully virtual, Saturday, Nov. 13 through Monday, Nov. 15, 2021, and is a premier global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular science for health care worldwide.
The award is given annually in honor of the late cardiovascular scientist Joseph A. Vita, M.D., to recognize research that had a major impact on the field of cardiovascular biology or cardiovascular health during the last five years. Dr. Vita was the founding editor of the Associations Open Access,peer-reviewed,Journal of the American Heart Association (JAHA). Dr. Musunuru is professor of medicine, scientific director of the Penn Center for Inherited Cardiovascular Disease and director of Genetic and Epigenetic Origins of Disease Program at the Cardiovascular Institute at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia. Dr. Rayner is a research scientist and director of the Cardiometabolic microRNA Laboratory at the University of Ottawa Heart Institute and assistant professor of biochemistry, microbiology and immunology at the University of Ottawa in Ottawa, Canada.
The research Drs. Musunuru and Rayner have conducted and continue to conduct to enhance understanding of cholesterol regulators and atherosclerosis is truly fascinating, said Association President Donald M. Lloyd-Jones, M.D., Sc.M., FAHA. Their research will serve as the inspiration for innovation in the management of cardiovascular disease for future generations. Congratulations to them both for their valuable contributions to our understanding of genetics and cardiovascular disease.
Dr. Musunuru was selected as a 2021 recipient of the Joseph A. Vita Award because of his impressive work in therapeutic gene editing to combat cardiovascular disease. Other key achievements include discovering an LDL cholesterol regulating gene, inspiring development of multiple ANGPTL3-inhibiting drugs, using gene-edited human stem cells for disease modeling, and his pivotal work in functional genomics. In his lab, Dr. Musunuru developed processes to use gene editing technology to permanently reduce cholesterol levels and therefore provide protection against heart attack and stroke through a one-time injection. This strategy, which he likens to a vaccination, has been very successful in mice and monkeys, and he is working diligently to advance it to human trials.
"I'm grateful to the American Heart Association for recognizing the ongoing efforts to translate cardiovascular gene editing from the research laboratory to clinical settings, and I'm honored to be given the opportunity to carry forward Dr. Vita's legacy, said Dr. Musunuru. None of my recent work would have been possible without strong mentorship and staunch support, past and present, especially from Sekar Kathiresan, Daniel Rader, Thomas Cappola and the leadership of the University of Pennsylvania.
Dr. Musunuru is board certified in internal medicine and cardiovascular disease and earned his Ph.D., in biomedical sciences from The Rockefeller University, a medical doctorate from Weill Cornell Medical College, a masters of public health in epidemiology from Johns Hopkins Bloomberg School of Public Health, and a masters in law from the University of Pennsylvania Law School. He completed a clinical fellowship in cardiology at Johns Hopkins Hospital and completed a clinical and research fellowship in cardiology at Massachusetts General Hospital in Boston. He is a past editor-in-chief and current senior consulting editor forCirculation: Genomic and Precision Medicine. Additionally, Dr. Musunuru serves on numerous committees at the Perelman School of Medicine at the University of Pennsylvania.
Dr. Musunuru has been an active member of the Association since 2007. He is a member of the planning committee for the High School Minority Outreach Program, a member of the Science and Clinical Education Lifelong Learning Committee, and chair of the task force for Modernization of AHA Scientific Statements. This is his sixth recognition from the Association, having previously been a finalist for the 2009 Jeremiah and Rose Stamler Research Award for New Investigators and winning the 2010 Functional Genomics and Translational Biology Young Investigator Award, the 2016 Award of Meritorious Achievement, the 2017 Functional Genomics and Epidemiology Mid-Career Research Award and Lecture, and the 2020 Council on Clinical Cardiology Distinguished Achievement Award.
Dr. Rayner was selected because of her contributions to cardiovascular research and her discovery of the critical role microRNAs play in regulating HDL cholesterol. She is dedicated to improving the understanding of the causality between inflammation and cardiometabolic disease. Dr. Rayners work, as well as the work of her research group, is continually recognized. Under her direction in the Cardiometabolic microRNA Laboratory at the University of Ottawa Heart Institute research is focused on how to use plaque instability triggered by inflammation in diagnosing patients with atherosclerotic disease, how macrophage function can be altered by microRNAs and how metabolic dysregulation in inflammatory cells and energy metabolism contribute to atherosclerosis. She is currently studying how to promote inflammation resolution and plaque regression within the aspects of atherosclerotic lesion dynamics.
Im honored to be recognized with this years Joseph A. Vita Award, said Dr. Rayner. Im fascinated by the relationship between inflammation and cardiometabolic disease. I hope recognition for this type of work helps to advance our understanding of these types of relationships and the role RNA can play in the treatment of diseases. The American Heart Association has always helped us communicate our findings to the wider scientific community, and I am grateful that the AHA journals continue to publish research of the highest quality, and I am honored to be recognized for my groups contributions.
Her research is focused on dysregulated inflammation in metabolic diseases, such as atherosclerotic vascular disease and exploring how RNA biology can be used in future therapies. Dr. Rayner is a graduate of the University of Ottawa. She completed her fellowship at Harvard Medical School and New York University School of Medicine. She is the director of the Cardiometabolic microRNA Laboratory at the University of Ottawa Heart Institute, and she is the. Dr. Rayner is part of the peer-review committees for the Canadian Institutes of Health Research, National Institutes of Health and the Heart and Stroke Foundation of Canada. She is an editorial board member forArteriosclerosis, Thrombosis and Vascular Biology;andCirculation Research.(Note: Both journals are published by the American Heart Association.)
Dr. Rayner is an active member of the Association who holds several leadership positions. She is the chair of the communications committee, past chair of the Early Career Committee and member of the leadership committee for the Arteriosclerosis, Thrombosis and Vascular Biology Council; member of the Council Operations Committee; and member of the Scientific Sessions Program Committee. This is her fourth award from the Association, having previously been recognized with the 2008 Junior Investigator Award for Women, 2010s Irving Page Young Investigator Award and 2019s Daniel Steinberg Early Career Investigator Award for her article Extracellular Vesicles Secreted by Atherogenic Macrophages Transfer MicroRNA to Inhibit Cell Migration.
Additional Resources:
The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers and the Associations overall financial information are availablehere.
The American Heart AssociationsScientific Sessions 2021is a premier global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular science for health care professionals worldwide. The three-day meeting will feature more than 500 sessions focused on breakthrough cardiovascular basic, clinical and population science updates in a fully virtual experience Saturday, Nov. 13 through Monday, Nov. 15, 2021. Thousands of leading physicians, scientists, cardiologists, advanced practice nurses and allied health care professionals from around the world will convene virtually to participate in basic, clinical and population science presentations, discussions and curricula that can shape the future of cardiovascular science and medicine, including prevention and quality improvement. During the three-day meeting, attendees receive exclusive access to more than 4,000 original research presentations and can earn Continuing Medical Education (CME), Continuing Education (CE) or Maintenance of Certification (MOC) credits for educational sessions. Engage in Scientific Sessions 2021 on social media via#AHA21.
About the American Heart Association
The American Heart Association is a leading force for a world of longer, healthier lives. With nearly a century of lifesaving work, the Dallas-based association is dedicated to ensuring equitable health for all. We are a trustworthy source empowering people to improve their heart health, brain health and well-being. We collaborate with numerous organizations and millions of volunteers to fund innovative research, advocate for stronger public health policies, and share lifesaving resources and information. Connect with us onheart.org,Facebook,Twitteror by calling 1-800-AHA-USA1.
###
See the original post:
Drs. Kiran Musunuru and Katey Rayner to be recognized with the American Heart Association's 2021 Joseph A. Vita Award - EurekAlert
- Best 30 Cardiology in Secaucus, NJ with Reviews - YP.com [Last Updated On: April 12th, 2018] [Originally Added On: April 12th, 2018]
- Cardiology | Weill Cornell Medicine [Last Updated On: April 14th, 2018] [Originally Added On: April 14th, 2018]
- Cardiology Conferences 2018 | Cardiology Meetings 2018 ... [Last Updated On: April 26th, 2018] [Originally Added On: April 26th, 2018]
- Dr. Anil Goel, MD - Birmingham, MI - Cardiology & Clinical ... [Last Updated On: April 26th, 2018] [Originally Added On: April 26th, 2018]
- Clinical Physiology (Cardiology) MSc/PGDip | Middlesex ... [Last Updated On: May 15th, 2018] [Originally Added On: May 15th, 2018]
- Cardiology Conferences 2018 | Upcoming Cardiology ... [Last Updated On: May 16th, 2018] [Originally Added On: May 16th, 2018]
- Clinical Cardiology Section | Cleveland Clinic [Last Updated On: May 27th, 2018] [Originally Added On: May 27th, 2018]
- Journal of Clinical and Experimental Cardiology - Open ... [Last Updated On: June 6th, 2018] [Originally Added On: June 6th, 2018]
- Cardiology Summit 2018 | Cardiology Conferences | Heart ... [Last Updated On: June 23rd, 2018] [Originally Added On: June 23rd, 2018]
- Cardiology Clinical and Research Faculty Members ... [Last Updated On: June 26th, 2018] [Originally Added On: June 26th, 2018]
- Cardiology Conferences 2018 | Cardiology Congress 2018 ... [Last Updated On: June 26th, 2018] [Originally Added On: June 26th, 2018]
- About Us - New Jersey Cardiology Associates [Last Updated On: July 8th, 2018] [Originally Added On: July 8th, 2018]
- About Us - Ventura Clinical Trials [Last Updated On: August 16th, 2018] [Originally Added On: August 16th, 2018]
- Clinical Cardiology Made Ridiculously Simple: Michael A ... [Last Updated On: August 22nd, 2018] [Originally Added On: August 22nd, 2018]
- Clinical Cardiology - American Society of Preventive Cardiology [Last Updated On: October 2nd, 2018] [Originally Added On: October 2nd, 2018]
- Heart Surgery Hospital in india | Cardiology Treatment ... [Last Updated On: October 7th, 2018] [Originally Added On: October 7th, 2018]
- Clinical Cardiology - American Society of Preventive ... [Last Updated On: December 3rd, 2018] [Originally Added On: December 3rd, 2018]
- Guideline Clinical App - American College of Cardiology [Last Updated On: December 7th, 2018] [Originally Added On: December 7th, 2018]
- Journal of Clinical and Experimental Cardiology- Open ... [Last Updated On: December 12th, 2018] [Originally Added On: December 12th, 2018]
- Clinical Cardiology - Baptist Health [Last Updated On: December 30th, 2018] [Originally Added On: December 30th, 2018]
- Cardiology at Cancun: Topics in Clinical Cardiology [Last Updated On: February 5th, 2019] [Originally Added On: February 5th, 2019]
- Department of Cardiovascular Medicine, KU School of Medicine [Last Updated On: March 10th, 2019] [Originally Added On: March 10th, 2019]
- Towards Health Equality: Improving the Management of Cardiovascular Diseases in Women - International Atomic Energy Agency [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Lifetime Risk of PAD Varies by Race, but All Are Vulnerable to Traditional Risk Factors - TCTMD [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF - TCTMD [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Combining Nature and Technology, Luye Medical and Cleveland Clinic Join to Build a Future Hospital in Shanghai - Yahoo Finance [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Will Renal Denervation for Hypertension Rise Again? - Medscape [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Obstructive Sleep Apnea, Sleep Symptoms, and their Association with Cardiovascular Disease - DocWire News [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- CNE expands pulmonary, sleep services with Brigham & Women's physicians - Warwick Beacon [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- What I Am Most Looking Forward to at TCT 2019 - TCTMD [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Serelaxin Not Linked to CV Mortality Reduction in Patients Hospitalized for Acute HF - The Cardiology Advisor [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Sacubitril-Valsartan Not Linked to Lower Hospitalization Risk, CV Death in HFpEF - The Cardiology Advisor [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- FDA clears multiuse angiography systems from Siemens Healthineers - DOTmed HealthCare Business News [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Balloon Pulmonary Angioplasty Effective for Chronic Thromboembolic PH - The Cardiology Advisor [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- RWJBarnabas Health, St. Luke's University Health launch clinical affiliation - FierceHealthcare [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Bilirubin: A Novel Indicator of Infective Endocarditis Adverse Outcomes - The Cardiology Advisor [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS - TCTMD [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Community-based Care Model Reduces CVD Risk - Managed Healthcare Executive [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- American College of Cardiology Steps Up: Equal Pay, Opportunities for All - TCTMD [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- FDA Approves Novo Nordisk's Oral Semaglutide, First GLP-1 in Pill Form - AJMC.com Managed Markets Network [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- A New Drug for HF? DEFINE-HF Bolsters Dapagliflozin Cardio Cred - Medscape [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Seeking Synergy: Bringing Cardiology into Your Enterprise Imaging Strategy - Health Imaging [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- TCT 2019 Day Two: Transcatheter Valves, New and Old - TCTMD [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis - TCTMD [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Bypass Surgery and Coronary Stenting Yield Comparable 10-Year Survival - Diagnostic and Interventional Cardiology [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3 - TCTMD [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Eidos Therapeutics to Present Interim Analysis of the Ongoing Phase 2 Open-Label Extension Study of AG10 in Patients with TTR Amyloid Cardiomyopathy... [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Off Script: The New Gatekeepers of Procedural Education - TCTMD [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Study Shows Safety and Efficacy of Near Infrared Spectroscopy (NIRS) Imaging to Identify Patients and Plaques at an Increased Risk for MACE - BioSpace [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- The Heart of the Matter: Cardiovascular Fitness in Horses - United States Eventing Association [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Google parent Alphabet hires former FDA head Robert Califf to lead health strategy and policy - FierceHealthcare [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Inclisiran Benefits Patients With Familial Hypercholesterolemia and ASCVD - The Cardiology Advisor [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- AUGUSTUS: Best Benefit With Apixaban, P2Y12 Inhibitor Dual Therapy - Medscape [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- New TAVR System Safe and Effective for High-Risk Surgical Patients with Severe Aortic Stenosis - Newswise [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Dapagliflozin Improves Heart Failure-Related Health Status in HFrEF - The Cardiology Advisor [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Remote Ischemic Conditioning Did Not Improve 12 Month Clinical Outcomes After STEMI - The Cardiology Advisor [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Insights from the European Society of Cardiology congress | Speaking of Medicine - PLoS Blogs [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Smokers Have More Pulmonary Emboli, Leading to Higher Hospital Readmission Rates | - Diagnostic and Interventional Cardiology [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- AZ's Farxiga gets heart failure prevention okay from FDA - PMLiVE [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Bayer Announces Recipients of the Pulmonary Hypertension Accelerated Bayer (PHAB) Awards at CHEST Annual Meeting 2019 - BioSpace [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- The Epidemic Of The Metabolic Syndrome Among The Palestinians In The G | DMSO - Dove Medical Press [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Optina Diagnostics and the Montreal Heart Institute Partner to Develop a New Biomarker for Atherosclerosis - PRNewswire [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Even With Same Diagnosis, Women Get Half the Heart Attack Treatments as Men - AJMC.com Managed Markets Network [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Eva Dickerman, Andrew Weil - The New York Times [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- EHR vendor Veradigm and partners creating new shared data tools for researchers - Healthcare IT News [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Evolocumab Well-tolerated as Add-on for Hypercholesterolemia Therapy - DocWire News [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Deborah Heart and Lung Center announces affiliation with Cleveland Clinic Heart & Vascular Institute - Health Essentials from Cleveland Clinic [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- New Registry to Provide Insight into STEMI Occurrence, Treatment in North India | - Diagnostic and Interventional Cardiology [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Finding Your Best Fit in Cardiology - TCTMD [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Cardiology team expands to meet community need - The Union of Grass Valley [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Deaths After Ablation of Atrial Fibrillation 'Concerning' in Real-World Analysis - TCTMD [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Cutler Family gifts $15 million to University Hospitals to transform mens health care - Newswise [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Troponin Increases After Elective PCI Tied to Complexity, Extent of CAD - TCTMD [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Caregiving and the Soul of Medicine - Medscape [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- STEMI Mortality Unaffected by Weekend, Weeknight, or Holiday Admission in France - TCTMD [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Cardiva Medical publishes positive results from the AMBULATE pivotal study Cardiology2.0 - Cardiology2.0 [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Gaps in Access to TAVR and SAVR: 'Something Needs to Be Done' - TCTMD [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Cardiva Medical Announces Publication of Data From the AMBULATE Pivotal Study in the Journal of the American College of Cardiology: Clinical... [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Raymond James 4 Analyst Favorite Health Care Picks With Huge Upside Potential - 24/7 Wall St. [Last Updated On: November 7th, 2019] [Originally Added On: November 7th, 2019]
- Global Computed Tomography (CT) Scanners Devices and Equipment Market Report 2020: Major Players are GE Healthcare, Koninklijke Philips, Hitachi,... [Last Updated On: November 7th, 2019] [Originally Added On: November 7th, 2019]